Latest market price
19.13
-1.31-6.41%
TA
Loading chart...
Snapshot
| Index | — | P/E | — | EPS (ttm) | -1.71 | Insider Own | — | Shs Outstand | 20.82M | Perf Week | -2.70% |
| Market Cap | 398.27M | Forward P/E | — | EPS next Y | -1.57 | Insider Trans | -1.91% | Shs Float | 18.19M | Perf Month | 2.03% |
| Enterprise Value | 314.27M | PEG | — | EPS next Q | -0.46 | Short Float | 3.90% | Perf Quarter | -14.52% | ||
| Income | -35.00M | P/S | 6.64 | EPS this Y | — | Short Ratio | 6.09 | Perf Half Y | 41.60% | ||
| Sales | 60.00M | P/B | 3.21 | EPS next Y | — | ROA | -23.05% | Short Interest | 710.11K | Perf YTD | 33.78% |
| Book/sh | 5.96 | P/C | 4.02 | EPS next 5Y | — | ROE | -25.67% | 52W High | 24.60 -22.24% | Perf Year | 63.23% |
| Cash/sh | 4.76 | P/FCF | — | EPS past 3/5Y | — | ROIC | -25.25% | 52W Low | 10.92 75.18% | Perf 3Y | — |
| Dividend Est. | — | EV/EBITDA | — | Sales past 3/5Y | — | Gross Margin | 77.34% | Volatility | 6.07% 5.14% | Perf 5Y | — |
| Dividend TTM | — | EV/Sales | 5.24 | EPS Y/Y TTM | — | Oper. Margin | -58.53% | ATR (14) | 1.06 | Perf 10Y | — |
| Dividend Ex-Date | — | Quick Ratio | 8.92 | Sales Y/Y TTM | 62.16% | Profit Margin | -58.33% | RSI (14) | 50.83 | Recom | 2.00 |
| Dividend Gr. 3/5Y | — | Current Ratio | 10.71 | EPS Q/Q | 28.65% | SMA20 | 1.33% | Beta | 0.28 | Target Price | 24.67 |
| Payout | 0.00% | Debt/Eq | 0.12 | Sales Q/Q | 54.55% | SMA50 | -0.28% | Rel Volume | 1.02 | Prev Close | 20.44 |
| Employees | 74 | LT Debt/Eq | 0.12 | Earnings | Nov 05 | SMA200 | 12.48% | Avg Volume | 117.00K | Price | 19.13 |
| IPO Date | Jul 31, 2025 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -0.32% 3.71% | Net Debt/EBITDA | — | Volume | 118,950 | Change | -6.41% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-12-26 | Reiterated | BTIG | Buy | $21 → $27 |
| Aug-10-26 | Reiterated | UBS | Buy | $27 → $28 |
| Jul-28-26 | Initiated | UBS | Buy | $27 |
| May-08-26 | Reiterated | Piper Sandler | Overweight | $18 → $19 |
| Dec-02-25 | Reiterated | Morgan Stanley | Overweight | $18 → $23 |
| Aug-25-25 | Initiated | Morgan Stanley | Overweight | $13 → $18 |
| Aug-25-25 | Initiated | Jefferies | Buy | $19 |
| Aug-25-25 | Initiated | Piper Sandler | Overweight | $18 |
| Aug-25-25 | Initiated | Goldman Sachs | Buy | $10 → $20 |
| Jan-09-23 | Reiterated | Morgan Stanley | $24 → $13 |
Latest News· Times ET
Oct-29-26
Oct-29-2608:00AM
Oct-27-26
Oct-24-26
02:02AM
Oct-21-26
11:00AM
Oct-15-26
Oct-15-2604:05PM
Oct-12-26
Oct-08-26
Oct-08-2609:02AM
07:00AM
Sep-30-26
Sep-30-2606:28AM
Sep-19-26
Sep-19-2604:03AM
Sep-15-26
Sep-15-2610:51PM
Sep-10-26
Sep-10-2604:05PM
Sep-09-26
Company
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | |
|---|---|---|---|---|---|
| Total Revenue | 60 | 47 | 32 | 19 | |
| Cost of Goods Sold Incl. D&A | 14 | 11 | 7 | 4 | |
| Gross Profit | 46 | 36 | 24 | 15 | |
| Selling, General and Administrative Excl. Other | 69 | 55 | 35 | 23 | |
| Research and Development | 12 | 8 | 4 | 3 | |
| Other Operating Expense | 1 | -1 | 0 | 0 | |
| Operating Income | -35 | -26 | -15 | -11 | |
| Interest Expense | -1 | 0 | 1 | 1 | |
| Unusual Expense | — | — | — | — | |
| Non-Operating Income (Expense) | -1 | -14 | 0 | -1 | |
| Net Income Before Taxes | -35 | -40 | -16 | -13 | |
| Income Taxes | 0 | 0 | 0 | 0 | |
| Consolidated Net Income | -35 | -40 | -16 | -13 | |
| Net Income From Continuing Operations | -35 | -40 | -16 | -13 | |
| Net Income | -35 | -40 | -16 | -13 | |
| EPS (Recurring) | -1.71 | -1.96 | -0.77 | -0.63 | |
| EPS (Basic, Before Extraordinaries) | -1.71 | -1.96 | -0.77 | -0.63 | |
| EPS (Diluted) | -1.71 | -1.96 | -0.77 | -0.63 | |
| EBITDA | -32 | -37 | -12 | -10 | |
| Other After Tax Adjustments | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | |
| Price To Sales Ratio | 6.70 | 6.39 | — | — | |
| Gross Margin | 76.67 | 76.60 | 75.00 | 78.95 | |
| Operating Margin | -58.33 | -55.32 | -46.88 | -57.89 | |
| Net Margin | -58.33 | -85.11 | -50.00 | -68.42 | |
| Shares Outstanding | 21 | 21 | 20 | 20 | |
| Market Capitalization | 402 | 300 | — | — | |
| Operating Lease Expense | — | — | — | — |
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Ball Robert Joseph | CEO & Executive Chairman | Sep 14 '26 | Option Exercise | 2.10 | 89,233 | 187,282 | 390,999 | Sep 14 |
| Ball Robert Joseph | CEO & Executive Chairman | Sep 14 '26 | Sale | 18.45 | 10,175 | 187,706 | 380,824 | Sep 14 |
| Gilde Healthcare Holding B.V. | 10% Owner | Aug 26 '26 | Sale | 22.60 | 1,196 | 27,030 | 2,185,914 | Aug 28 |
| Gilde Healthcare Holding B.V. | 10% Owner | Aug 24 '26 | Sale | 22.62 | 681 | 15,404 | 2,187,110 | Aug 24 |
| Gilde Healthcare Holding B.V. | 10% Owner | Aug 21 '26 | Sale | 22.61 | 20,516 | 463,867 | 2,187,791 | Aug 24 |
| Gilde Healthcare Holding B.V. | 10% Owner | Aug 20 '26 | Sale | 22.60 | 3,900 | 88,140 | 2,208,307 | Aug 24 |
| Ahearn Matthew Fraser | Chief Operating Officer | Aug 18 '26 | Sale | 20.99 | 14,186 | 297,704 | 244,176 | Aug 18 |
| Ahearn Matthew Fraser | Chief Operating Officer | Aug 17 '26 | Sale | 20.10 | 8,314 | 167,101 | 258,362 | Aug 18 |
| Gilde Healthcare Holding B.V. | 10% Owner | Aug 06 '26 | Sale | 22.60 | 2,095 | 47,347 | 2,212,207 | Aug 07 |
| Gilde Healthcare Holding B.V. | 10% Owner | Aug 05 '26 | Sale | 22.64 | 7,338 | 166,132 | 2,214,302 | Aug 07 |
| Gilde Healthcare Holding B.V. | 10% Owner | Aug 04 '26 | Sale | 22.77 | 99,812 | 2,272,719 | 2,221,640 | Aug 05 |
| Gilde Healthcare Holding B.V. | 10% Owner | Aug 03 '26 | Sale | 22.71 | 10,751 | 244,155 | 2,321,452 | Aug 05 |
| Gilde Healthcare Holding B.V. | 10% Owner | Jul 31 '26 | Sale | 22.73 | 20,034 | 455,373 | 2,332,203 | Aug 03 |
| Gilde Healthcare Holding B.V. | 10% Owner | Jul 30 '26 | Sale | 23.36 | 28,245 | 659,803 | 2,352,237 | Aug 03 |
| Ahearn Matthew Fraser | Chief Operating Officer | Jun 15 '26 | Sale | 18.84 | 4,144 | 78,070 | 269,176 | Jun 16 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.